StocksFin Logo
Takeda Pharmaceutical Company Limited country of incorporation
|
|
Mr. Christophe Weber
|
47,347 employees
NYSE | Healthcare | Drug Manufacturers—Specialty & Generic
AmerisourceBergen Corporation country of incorporation
|
|
Mr. Steven Collis
|
39,000 employees
NYSE | Healthcare | Medical Distribution
Q223 reported Sep 30, 2022 Reporting Period
$1T 18.6% vs. Q222 Revenues Q223
69.53% 3.2% vs. Q222 Gross Profit Margin
6.16% 13.2% vs. Q222 Net Profit Margin
180.38B -22.6% vs. Q222 Free Cash Flow Q223
$10 0% vs. Q222 EPS Q223
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q223
0.25%
Q123
0.29%
Q123 reported Feb 1, 2023 Reporting Period
$62.85B 5.4% vs. Q122 Revenues Q123
3.41% -1.2% vs. Q122 Gross Profit Margin
0.76% 1.4% vs. Q122 Net Profit Margin
167.22M -80.6% vs. Q122 Free Cash Flow Q123
$2.35 9.3% vs. Q122 EPS Q123
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q223
0.25%
Q123
0.29%
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Dec 31, 2022
Quick Ratio
0.68
0.45
Current Ratio
1.15
0.91
Cash Ratio
0.33
0.04
Price to Book
0.66
459.63
Price to Sales
4.42
0.54
Price to Earnings
17.95
17.62